Form 8-K - Current report:
SEC Accession No. 0001104659-25-002859
Filing Date
2025-01-13
Accepted
2025-01-13 07:36:46
Documents
16
Period of Report
2025-01-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm253090d1_8k.htm   iXBRL 8-K 55439
2 EXHIBIT 10.1 tm253090d1_ex10-1.htm EX-10.1 841615
3 EXHIBIT 10.2 tm253090d1_ex10-2.htm EX-10.2 89472
4 EXHIBIT 99.1 tm253090d1_ex99-1.htm EX-99.1 25691
  Complete submission text file 0001104659-25-002859.txt   1408076

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vstm-20250113.xsd EX-101.SCH 3015
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vstm-20250113_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vstm-20250113_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT tm253090d1_8k_htm.xml XML 3675
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35403 | Film No.: 25524826
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)